CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,648 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03068494
NCT03068494N/ACompleted

Multicenter, Retrospective Korean Coronary Bifurcation Stenting (COBIS) Registry III

Samsung Medical Center·observational·Posted Mar 1, 2017·Updated May 8, 2019

In Brief

An observational study for Coronary Bifurcation Lesion. Completed, enrolled 2,648 participants across 1 site.

Detailed Summary

The COBIS III registry is a multi-center, real-world registry of 2nd generation drug-eluting stenting in coronary bifurcation lesions in South Korea. From 21 major coronary intervention centers in Korea, a total of 3,000 patients (anticipated) will be enrolled in this database between January 2010 and December 2014. The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with 2nd generation drug-eluting stents for coronary bifurcation lesions in South Korea.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 1, 2017
Enrollment StartFeb 28, 2017
Primary CompletionDec 29, 2018
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.3 years ago